{
  "meta": {
    "id": "test84",
    "title": "Interstitial Lung Disease (Part 1)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Byssinosis occurs due to?",
      "options": [
        {
          "label": "A",
          "text": "Cotton fiber",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sugarcane",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspergillus clavatus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Proteins in bird droppings",
          "correct": false
        }
      ],
      "correct_answer": "A. Cotton fiber",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cotton fiber Byssinosis = cotton fiber Clinical features:- 4-6h post-exposure : Fever, rigors, myalgia , dry cough, dyspnea, crackles (no wheeze). Chronic: Weight loss , exertional dyspnea, Type I respiratory failure , cor pulmonale. Tests:- In Acute Exposure: CXR : mid-zone mottling/consolidation. Lung function tests: r eversible restrictive defect Q; reduced gas transfer Q during acute attacks. In Chronic exposure : Blood tests: positive serum precipitins. CXR: upper-zone fibrosis; honeycomb lung. Lung function tests: persistent changes as above. Bronchoalveolar lavage (BAL) fluid shows t lymphocytes and mast cells</p>\n<p><strong>Extraedge:</strong></p><p>Treatment:- Acute attack: Remove allergen and give O2, then Oral prednisolone. Chronic: Avoid exposure to allergens. Long-term steroids.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d289793b",
      "audio": ""
    },
    {
      "text": "In primary pulmonary hypertension, fundamental abnormality in genes lies in the:",
      "options": [
        {
          "label": "A",
          "text": "Bone morphogenic protein receptor II",
          "correct": true
        },
        {
          "label": "B",
          "text": "Endothelin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Homeobox gene",
          "correct": false
        },
        {
          "label": "D",
          "text": "PAX-II",
          "correct": false
        }
      ],
      "correct_answer": "A. Bone morphogenic protein receptor II",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Bone morphogenic protein receptor II PAH</p>\n<p><strong>Highyeild:</strong></p><p>Definitions:- Pulmonary hypertension elevation of mean pulmonary artery pressure to >25 mm Hg at rest or >30 mm Hg with exercise. WHO has defined PAH as present when a systolic pulmonary artery pressure is > 40 mm Hg, corresponding to tricuspid regurgitation on a Doppler echocardiogram of 3-3.5 m/sec. Pulmonary hypertension is primary or secondary in origin. Primary pulmonary hypertension (PPH) is Idiopathic. Fundamental abnormality in gene lies in Bone morphogenic protein receptor II (BMPR II) Secondary pulmonary hypertension</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: B. The gene does not lie in the endothelial cells Option: C. Homeobox gene is not related to primary pulmonary hypertension Option: D. PAX-II is not related</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "71677429",
      "audio": ""
    },
    {
      "text": "Interstitial lung disease (ILD) is an umbrella term used for a large group of diseases that cause scarring (fibrosis) of the lungs. The scarring causes lung stiffness, making breathing difficult and getting oxygen to the bloodstream difficult. Lung damage from ILDs is often irreversible and gets worse over time. Which of the following cytokine is most potent and fibrogenic?",
      "options": [
        {
          "label": "A",
          "text": "PDGF",
          "correct": false
        },
        {
          "label": "B",
          "text": "TGF beta",
          "correct": true
        },
        {
          "label": "C",
          "text": "TNF - alpha",
          "correct": false
        },
        {
          "label": "D",
          "text": "IL-1",
          "correct": false
        }
      ],
      "correct_answer": "B. TGF beta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>TGF beta All white blood cell lineages produce TGF Beta proteins . TGF-\u03b2 is upregulated and activated in fibrotic diseases and modulates fibroblast phenotype and function, inducing myofibroblast transdifferentiation while promoting matrix preservation. TGF Beta is the most critical fibrogenic cytokine.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0c016e22",
      "audio": ""
    },
    {
      "text": "A 75-year-old male patient has dyspnea, tachypnea, end-inspiratory crackles, and eventual cyanosis without wheezing or other evidence of airway obstruction. The classic functional abnormalities are reductions in diffusion capacity, lung volume, and lung compliance. Chest radiographs show bilateral lesions that take the form of small nodules, irregular lines, or ground-glass shadows. Which of the following can be the most appropriate diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "COPD",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interstitial lung disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bronchiectasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Asthma",
          "correct": false
        }
      ],
      "correct_answer": "B. Interstitial lung disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Interstitial lung disease Chronic interstitial pulmonary diseases are a heterogeneous group of disorders characterized predominantly by inflammation and fibrosis of the lung interstitium associated with pulmonary function studies indicative of restrictive lung disease . Velcro creps are associated with it.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ed4976bb",
      "audio": ""
    },
    {
      "text": "A 76-year-old male suffers from a restrictive lung condition, which can be explained as a clinicopathologic syndrome marked by progressive interstitial pulmonary fibrosis and respiratory failure. HRCT shows Bilateral subpleural reticular changes most prominent in lower, posterior lung zones. It is the most common type of interstitial lung disease. Identify the condition?'",
      "options": [
        {
          "label": "A",
          "text": "Idiopathic pulmonary fibrosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Idiopathic interstitial pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "COPD",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonspecific interstitial pneumonia",
          "correct": false
        }
      ],
      "correct_answer": "A. Idiopathic pulmonary fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Idiopathic pulmonary fibrosis Chronic interstitial lung diseases, or we can call them idiopathic interstitial pneumonia, are divided into various subtypes. The most common of them is idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis (IPF) is a clinicopathologic syndrome marked by progressive interstitial pulmonary fibrosis and respiratory failure. IPF can lead to the honeycombing of the Lungs. HRCT finding showing reticular opacities at lung base = IPF is the diagnosis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: B. Idiopathic interstitial pneumonia does not present with reticular changes. The other characteristics are not seen. Option: C. COPD does not present the above features Option: D . NISP is not related to the above symptoms</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3375fe6f",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presented with Symptoms including tightening of the skin, joint pain, exaggerated response to cold, and the following finding - Identify the most commonly associated lung finding with this condition.",
      "options": [
        {
          "label": "A",
          "text": "Usual interstitial pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Idiopathic pulmonary fibrosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nonspecific interstitial fibrosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Chronic pleuritis",
          "correct": false
        }
      ],
      "correct_answer": "C. Nonspecific interstitial fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nonspecific interstitial fibrosis Joint pain - arthritis Exaggerated response to cold - Raynaud's phenomenon Therefore, it must be a connective tissue disorder , and the diagnosis can be systemic sclerosis. The image of scleroderma confirms the patient to be having sclerosis. The most common lung finding in a sclerosis patient is NSIP, whereas the most common lung finding in a patient of Rheumatoid Arthritis is UIP. Systemic sclerosis (scleroderma) is associated with diffuse interstitial fibrosis (nonspecific interstitial pattern more common than usual) and pleural involvement.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5516fe3d",
      "audio": ""
    },
    {
      "text": "A 52-year-old patient presented to OPD with a subacute flu-like illness, cough, dyspnea, fever, and fatigue. Inspiratory rales are present on examination, and patients are noted to have restrictive lung deficits on pulmonary function testing with hypoxemia. The patient is suffering from polymyositis. Radiological imaging findings include patchy, sometimes migratory, subpleural consolidative opacities, often with associated ground-glass opacities. The underlying lung architecture is normal. There is no interstitial fibrosis or honeycomb lung. Histologically, it shows polypoid plugs of loose organizing connective tissue \u2018Masson bodies\u2019 within alveolar ducts, alveoli, and often bronchioles. What is the appropriate diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Nonspecific interstitial pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cryptogenic organizing pneumonia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Idiopathic pulmonary fibrosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Langerhans cell histiocytosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Cryptogenic organizing pneumonia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cryptogenic organizing pneumonia It is a Subacute flu-like illness. Inspiratory rales and restrictive pattern - ILD Polymyositis - connective tissue disorder - looking at it, we can think of NSIP, or COP ( cryptogenic organizing pneumonia) Radiology - migratory opacity - subpleural - ground glass , lung architecture standard, no honeycombing - NSIP is less likely because it has diffuse symmetric bilateral ground glass opacities and can spare subpleural area. Masson bodies present - diagnosis of COP can be confirmed.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: A. . Non-specific interstitial pneumonia does not present with ground glass opacities and the different characteristics are not seen. Option: C. Idiopathic pulmonary fibrosis does not present with the above features Option: D. Langerhans cell histiocytosis is not related to the above symptoms, and Masson bodies are not present in the above condition</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f95f244f",
      "audio": ""
    },
    {
      "text": "A patient on Amiodarone therapy visited OPD with difficulty breathing for three months. On seeing the drug history, the attending physician suspected amiodarone-induced fibrosis. Interstitial pneumonitis usually presents after two or more months of therapy, especially in patients whose amiodarone dose exceeds 400 mg daily. Which of the following drug is least commonly related to Interstitial lung diseases?",
      "options": [
        {
          "label": "A",
          "text": "Bleomycin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Busulfan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": true
        }
      ],
      "correct_answer": "D. Cyclophosphamide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cyclophosphamide The parent drug cyclophosphamide is nontoxic to the lung since it is metabolized in the liver, and to a lesser extent in the lung, to the toxic metabolites 4-hydroxy cyclophosphamide [recent INICET], acrolein, and phosphoramide mustard.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Bleomycin is a chemotherapeutic agent commonly used to treat curable diseases such as germinative tumors and Hodgkin's lymphoma. The lung injury following bleomycin comprises interstitial edema with an influx of inflammatory and immune cells. This may lead to the development of pulmonary fibrosis, characterized by enhanced production and deposition of collagen and other matrix components. Option: B. Busulfan can cause i nterstitial fibrosing lung disease (\u201cbusulfan lung\u201d ) with an estimated incidence of 6% . It begins gradually, causes dyspnea and cough, and is often accompanied by skin pigmentation. Option: C. Methotrexate It is used to treat a variety of malignancies, connective tissue diseases, and Severe toxicity from methotrexate may affect the lungs, liver, and bone marrow.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e69dbdf",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presented to opd with dyspnea on exertion and a persistent dry cough for two years. The patient had a 75-pack-year history of smoking. A pulmonary function test revealed restrictive lung pathology, and the patient was suspected of having smoking-associated interstitial lung disease. Which of the following is the least possible diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Desquamative Interstitial Pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary Langerhans cell histiocytosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pulmonary lymphangiomyomatosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Respiratory bronchiolitis associated ILD",
          "correct": false
        }
      ],
      "correct_answer": "C. Pulmonary lymphangiomyomatosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pulmonary lymphangiomyomatosis Smoking-related diseases can be grouped into obstructive diseases (emphysema and chronic bronchitis, already discussed) and restrictive or interstitial diseases. A majority of individuals with idiopathic pulmonary fibrosis are smokers. Desquamative interstitial pneumonia and respiratory bronchiolitis\u2013associated interstitial lung disease are two other smoking-associated interstitial lung diseases worthy of brief mention.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Desquamative Interstitial Pneumonia is characterized by extensive collections of macrophages in the airspaces of a current or former smoker. The macrophages were initially thought to be desquamated pneumocytes\u2014thus the misnomer \u201c desquamative interstitial pneumonia. \u201d The most striking finding is the accumulation of many macrophages with abundant cytoplasm containing dusty brown pigment (smokers\u2019 macrophages) in the airspaces. Option: B. Pulmonary Langerhans cell histiocytosis is a rare disease characterized by focal collections of Langerhans cells (often accompanied by eosinophils). More than 90% of affected patients are relatively young adult smokers or ex-smokers; among smokers, about half improve after smoking cessation. Option: D. Respiratory bronchiolitis\u2013associated interstitial lung disease is marked by chronic inflammation and peribronchiolar fibrosis. It is a typical histologic lesion in cigarette smokers.</p>\n<p><strong>Extraedge:</strong></p><p>Respiratory bronchioles, alveolar ducts, and peribronchiolar spaces contain aggregates of dusty brown macrophages (smokers\u2019 macrophages) similar to those seen in desquamative interstitial pneumonia. Langerhans cell histiocytosis occurs in Young men ILD with pneumothorax can be the presentation. smoking-related ILDs, including respiratory bronchiolitis with interstitial lung disease (RB-ILD) and DIP, are frequently subclassified with the IIPs, these disorders along with PLCH, an ILD with unique clinical, imaging, and histopathologic manifestations) are commonly felt to result from active or prior tobacco smoke exposure. These disorders predominantly occur in active and, in many cases, heavy smokers who are typically between 40 and 50. Dyspnea and cough are relatively common and symptomatic in those diagnosed with RB-ILD or DIP.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56d4b050",
      "audio": ""
    },
    {
      "text": "A 30-year-old male with progressively worsening dyspnea and non-productive cough for one year. He was a sugar cane plantation worker and had prior recurrent respiratory infections. A physical exam revealed cyanosis and bilateral fine rales. Chest computed tomography showed a diffuse crazy paving pattern.",
      "options": [
        {
          "label": "A",
          "text": "Pneumocystis carini pneumonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary alveolar proteinosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "ARDS",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonspecific interstitial pneumonia",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary alveolar proteinosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pulmonary alveolar proteinosis Keywords - 30-year-old male non-productive cough sugar cane plantation worker with recurrent respiratory infections, cyanosis, and bilateral fine rales diffuse crazy paving pattern thick whitish proteinaceous protein eosinophilic PAS-positive macrophage.</p>\n<p><strong>Highyeild:</strong></p><p>These features point toward diagnosing \u201c pulmonary alveolar proteinosis. \u201c Pulmonary alveolar proteinosis (PAP) is a rare disease caused by defects in pulmonary macrophage function due to deficient granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling, which results in the accumulation of surfactant in the intra-alveola r and bronchiolar spaces. PAP is associated with a crazy paving appearance. bilateral patchy a symmetric pulmonary opacifications. the disease is characterized by the accumulation of intra-alveolar precipitates containing surfactant proteins , causing focal-to-confluent consolidation of large areas of the lungs with minimal inflammatory reaction. a marked increase in the size and weight of the lung. The alveolar precipitate is pink, homogeneous, and periodic acid\u2013Schiff\u2013positive macrophages. Progressive dyspnea, cyanosis, and respiratory insufficiency may occur. Whole-lung lavage is the standard of care.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Infective causes are less likely here; no associated history of HIV or immunocompromised state, which is common in pneumocystis carini pneumonia Option: C. ARDS is a severe, life-threatening condition, b/l diffuse pulmonary infiltrates. But not related to the clinical profile of the patient. No PAS-positive material. Option: D. NSIP - it is related to connective tissue disease, which also occurs in older patients.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b285a6c2",
      "audio": ""
    },
    {
      "text": "The patient is a 41-year-old woman with a history of hypertension and dyslipidemia. She presented to the emergency department at another institution with sudden shortness of breath and left-sided pleuritic chest pain. Left pneumothorax was diagnosed, and a chest tube was placed. Before this admission, she experienced multiple episodes of spontaneous pneumothorax over the past 17 years, resolved without intervention. She reported smoking tobacco, less than two cigarettes per day, for the past 21 years. Computed tomography (CT) scan of the chest revealed multiple, thin-walled cysts in both lungs of variable dimensions. Serum VEGF - D = 925pgml. The patient also suffers from an Autosomal dominant condition, which can be seen as - What is the most appropriate diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Langerhans cell histiocytosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary lymphangiomyomatosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Nonspecific interstitial pneumonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bronchiolitis obliterans",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary lymphangiomyomatosis",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855899401-QTDM147014IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pulmonary lymphangiomyomatosis The clinical condition, which is autosomal dominant, looks like tuberous sclerosis because facial features suggest facial angiofibroma . It is associated with cortical tubers and can be associated with epilepsy Recurrent pneumothorax points towards - Langerhans cell histiocytosis and pulmonary lymphangiomyomatosis (LAM) But Langerhans cell histiocytosis affects young males, whereas pulmonary LAM affects young females. Let's look at other features - Serum VEDF-G is 925, i.e. elevated And the patient has tuberous sclerosis So the diagnosis should be pulmonary LAM.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Langerhans cell histiocytosis - affects young males and is associated with recurrent pneumothorax, but VEDF - G and TS association is absent. Option: C. NSIP is unrelated to pneumothorax and VEDF - G. Option: D. bronchiolitis obliterans is associated with emphysema but does not affect young patients.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dd59071a",
      "audio": ""
    },
    {
      "text": "A 40-year-old female patient was referred to AIIMS. Her medical history and the documentation she presented revealed that the patient was diagnosed with scleroderma, and she had been treated in the Department of Rheumatology at Istanbul University Faculty of Medicine for 20 years. She had a goiter and gastric disease. Serum anti-topoisomerase, also known as SCL-70, is optimistic; which of the following is this patient's most specific lung finding?",
      "options": [
        {
          "label": "A",
          "text": "Emphysema",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary artery hypertension",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nonspecific interstitial pneumonia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bronchiectasis",
          "correct": false
        }
      ],
      "correct_answer": "C. Nonspecific interstitial pneumonia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nonspecific interstitial pneumonia Limited vs. Diffuse Scleroderma Limited Diffuse Calcinosis ++ + Arthralgia/Arthritis ++ ++++ Pulmonary fibrosis + ++ Pulmonary HTN + 0 Tendon Friction Rubs 0 +++ Renal crisis 0 + Centromere Ab* ++++ + Anti-Scl-70 Ab* + ++ *Ab: antibody +elative percentages: +++++81-100%; ++++61-80%; +++ 41-60%; ++21-40%; + 1-20% Hachulla E, Clin Rev Allergy Immunol 2011;40:78-83</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. emphysema - it is not related to systemic sclerosis. Option: B. Pulmonary artery hypertension is the specific finding of limited systemic sclerosis. The antibody specific here will be anti- And the features will include typical CREST syndrome. Option: D. Bronchiectasis is not associated with systemic sclerosis. The diagnosis of scleroderma is given. Anti topoisomerase antibody or anti-SCL - 70 antibody is specific to diffuse scleroderma. The most common lung finding here is an interstitial lung disease, i.e... NSIP. Most rheumatological disorders are associated with NSIP as lung disease.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abaf323a",
      "audio": ""
    }
  ]
}